[HTML][HTML] Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
Purpose Although the prevalence of community-acquired respiratory bacterial coinfection
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …
[引用][C] Procalcitonin and c-reactive protein to rule out early bacterial coinfection in covid-19 critically ill patients
F Galli, F Bindo, A Motos… - Intensive Care …, 2023 - digibuo.uniovi.es
Procalcitonin and c-reactive protein to rule out early bacterial coinfection in covid-19
critically ill patients RUO Principal Repositorio Institucional de la Universidad de Oviedo Ver …
critically ill patients RUO Principal Repositorio Institucional de la Universidad de Oviedo Ver …
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
CIBERESUCICOVID Project investigators - Intensive Care Medicine, 2023 - merit.url.edu
Purpose: Although the prevalence of community-acquired respiratory bacterial coinfection
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …
[PDF][PDF] Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
F Galli, F Bindo, A Motos, L Fernández‑Barat… - Intensive Care …, 2023 - repositori.udl.cat
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19
critically ill patients Page 1 Intensive Care Med (2023) 49:934–945 https://doi.org/10.1007/s00134-023-07161-1 …
critically ill patients Page 1 Intensive Care Med (2023) 49:934–945 https://doi.org/10.1007/s00134-023-07161-1 …
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients.
F Galli, F Bindo, A Motos, L Fernández-Barat… - Intensive Care …, 2023 - europepmc.org
Purpose Although the prevalence of community-acquired respiratory bacterial coinfection
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
F Galli, F Bindo, A Motos, L Fernández-Barat… - Intensive care …, 2023 - docusalut.com
Although the prevalence of community-acquired respiratory bacterial coinfection upon
hospital admission in patients with coronavirus disease 2019 (COVID-19) has been reported …
hospital admission in patients with coronavirus disease 2019 (COVID-19) has been reported …
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
F Galli, F Bindo, A Motos, L Fernández-Barat… - 2023 - ebuah.uah.es
Purpose: Although the prevalence of community-acquired respiratory bacterial coinfection
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients.
F Galli, F Bindo, A Motos, MC Martín Delgado, A Torres - 2023 - ddfv.ufv.es
Purpose Although the prevalence of community-acquired respiratory bacterial coinfection
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
F Galli, F Bindo, A Motos… - Intensive care …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose Although the prevalence of community-acquired respiratory bacterial coinfection
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …
[引用][C] Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
F Galli, F Bindo, A Motos… - Intensive Care …, 2023 - portalcientifico.uah.es
Purpose: Although the prevalence of community-acquired respiratory bacterial coinfection
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …
upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been …